• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,094.07 291.17
( 0.38%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
391.1437121
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
35.83
86995.37
EPS(TTM)
Face Value()
Div & Yield %
41.81
1
0.27
 

Alkem Laboratories consolidated net profit declines 22.69% in the March 2026 quarter
May 28,2026
Net profit of Alkem Laboratories declined 22.69% to Rs 236.46 crore in the quarter ended March 2026 as against Rs 305.86 crore during the previous quarter ended March 2025. Sales rose 14.62% to Rs 3603.32 crore in the quarter ended March 2026 as against Rs 3143.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 6.30% to Rs 2301.80 crore in the year ended March 2026 as against Rs 2165.48 crore during the previous year ended March 2025. Sales rose 13.48% to Rs 14712.27 crore in the year ended March 2026 as against Rs 12964.52 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3603.323143.75 15 14712.2712964.52 13
OPM %14.3612.45 -20.4319.38 -
PBDT663.58508.83 30 3427.782884.19 19
PBT557.82396.34 41 3045.722527.03 21
NP236.46305.86 -23 2301.802165.48 6